Skip to Content

M 177 (Divalproex Sodium Extended-Release 250 mg)

Pill with imprint M 177 is White, Round and has been identified as Divalproex Sodium Extended-Release 250 mg. It is supplied by Mylan Pharmaceuticals Inc..

Divalproex sodium is used in the treatment of bipolar disorder; mania; epilepsy; migraine prevention and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M 177

Divalproex sodium extended-release 250 mg M 177
Divalproex sodium extended-release 250 mg M 177
Divalproex sodium extended-release 250 mg M 177 Front
Divalproex sodium extended-release 250 mg M 177 Back
Divalproex sodium extended-release 250 mg M 177
Divalproex sodium extended-release 250 mg M 177

Divalproex Sodium Extended-Release

Imprint
M 177
Strength
250 mg
Color
White
Size
12.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Fatty acid derivative anticonvulsants
Pregnancy Category
D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder, X - Not for use in pregnancy - When treating migraine
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
Inactive Ingredients
ammonia, silicon dioxide, dibutyl sebacate, oleic acid, polydextrose, microcrystalline cellulose, titanium dioxide, triacetin

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00378-0472 Mylan Pharmaceuticals Inc.
51079-0766 UDL Laboratories Inc.

Get help with Imprint Code FAQs.

Related Images for "M 177"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.